AB
INDV icon

Amalgamated Bank’s Indivior Pharmaceuticals INDV Stock Holding History

Amalgamated Bank’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Sell
32,698
-3,135
-9% -$114K 0.01% 990
2026
Q1 		$1.09M Sell
35,833
-343
-0.9% -$11.3K 0.01% 1030
2025
Q4 		$1.3M Buy
36,176
+32,033
+773% +$978K 0.01% 980
2025
Q3 		$100K Hold
4,143
– – ﹤0.01% 1700
2025
Q2 		$61K Buy
+4,143
New +$48.3K ﹤0.01% 1787

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Amalgamated Bank's INDV Position: Q2 2026 in Review

Amalgamated Bank reduced its Indivior Pharmaceuticals (INDV) stake by 8.7% in Q2 2026, selling an estimated $114K and leaving 32,698 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #990.

Amalgamated Bank first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. 144 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Amalgamated Bank held 32,698 shares of Indivior Pharmaceuticals worth $1.34M as of Q2 2026.
  • Amalgamated Bank sold 3,135 Indivior Pharmaceuticals shares in Q2 2026, an estimated $114K.
  • Indivior Pharmaceuticals made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #990 holding.
  • Amalgamated Bank first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 144 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.